<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0100279'>Ulcerative colitis</z:hpo> (UC) patients are at increased risk of colorectal <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Few studies have examined the clinical outcomes of dysplastic <z:mpath ids='MPATH_491'>polyps</z:mpath> resembling <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_270'>adenomas</z:mpath> that are removed with endoscopic polypectomy </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A centralized diagnostic index identified patients evaluated between 1994 and 2004 with UC and polypoid <z:mpath ids='MPATH_589'>dysplasia</z:mpath> who were followed from the time of polypectomy until the most recent colonoscopy </plain></SENT>
<SENT sid="3" pm="."><plain>They were stratified into two groups by <z:mpath ids='MPATH_491'>polyp</z:mpath> occurrence, either within (<z:mpath ids='MPATH_270'>adenoma</z:mpath>-like <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) or outside (<z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_270'>adenoma</z:mpath>) the most proximal endoscopic or histologic extent of <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The endpoints of interest were the development of subsequent colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, flat <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The cumulative probabilities of these endpoints were estimated using the Kaplan-Meier method, and the association with clinical factors assessed using Cox proportional hazards regression </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Ninety-five patients were found to have polypoid <z:mpath ids='MPATH_589'>dysplasia</z:mpath>; of these, 77 underwent polypectomy </plain></SENT>
<SENT sid="7" pm="."><plain>The cumulative probability of subsequent colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in polypectomy patients was 18% at 1 year and 69% at 5 years </plain></SENT>
<SENT sid="8" pm="."><plain>After polypectomy, cumulative incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or flat <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was 2% at 1 year and 13% at 5 years </plain></SENT>
<SENT sid="9" pm="."><plain>The proportional hazards models indicated that these outcomes were not significantly associated with <z:mpath ids='MPATH_491'>polyp</z:mpath> type, primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp>, family history of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:chebi fb="0" ids="20551">5-aminosalicylate</z:chebi> use, extent of <z:hpo ids='HP_0002583'>colitis</z:hpo>, or duration of disease </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: While polypectomy may be safe for the management of <z:mpath ids='MPATH_270'>adenomas</z:mpath> occurring in most UC patients, the 5-year cumulative incidence of a combined endpoint (<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or flat <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) was 13% </plain></SENT>
<SENT sid="11" pm="."><plain>Such patients should be followed closely </plain></SENT>
</text></document>